Sarepta Therapeutics Inc. historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2025-11-03 | 6.650 | 6.650 | 6.100 | 6.230 | 6.230 | 479 |
| 2025-10-31 | 6.160 | 6.160 | 6.160 | 6.160 | 6.160 | 0 |
| 2025-10-30 | 6.340 | 6.340 | 6.160 | 6.160 | 6.160 | 131 |
| 2025-10-29 | 6.430 | 6.430 | 6.230 | 6.270 | 6.270 | 133 |
| 2025-10-28 | 6.400 | 6.490 | 6.400 | 6.420 | 6.420 | 1,748 |
| 2025-10-27 | 6.270 | 6.350 | 6.270 | 6.350 | 6.350 | 627 |
| 2025-10-24 | 6.020 | 6.210 | 5.980 | 6.150 | 6.150 | 26,750 |
| 2025-10-23 | 6.150 | 6.150 | 5.740 | 5.940 | 5.940 | 26,629 |
| 2025-10-22 | 6.270 | 6.270 | 6.080 | 6.080 | 6.080 | 25 |
| 2025-10-21 | 6.220 | 6.220 | 6.220 | 6.220 | 6.220 | 51 |
| 2025-10-20 | 6.280 | 6.290 | 6.220 | 6.230 | 6.230 | 401 |
| 2025-10-17 | 6.280 | 6.280 | 5.960 | 6.210 | 6.210 | 304 |
| 2025-10-16 | 6.080 | 6.390 | 6.080 | 6.330 | 6.330 | 5,180 |
| 2025-10-15 | 5.800 | 6.050 | 5.800 | 6.040 | 6.040 | 3,795 |
| 2025-10-14 | 6.000 | 6.000 | 5.780 | 5.920 | 5.920 | 7,063 |
| 2025-10-13 | 6.120 | 6.120 | 5.860 | 5.930 | 5.930 | 206 |
| 2025-10-10 | 6.390 | 6.390 | 6.090 | 6.150 | 6.150 | 1,853 |
| 2025-10-09 | 6.420 | 6.460 | 6.310 | 6.320 | 6.320 | 6,675 |
| 2025-10-08 | 6.350 | 6.670 | 6.160 | 6.260 | 6.260 | 2,895 |
| 2025-10-07 | 6.290 | 6.320 | 6.110 | 6.110 | 6.110 | 2,081 |
| 2025-10-06 | 6.200 | 6.250 | 6.080 | 6.220 | 6.220 | 2,037 |
| 2025-10-03 | 6.010 | 6.010 | 5.840 | 6.010 | 6.010 | 4,352 |
| 2025-10-02 | 5.120 | 6.200 | 5.120 | 5.990 | 5.990 | 34,715 |
| 2025-10-01 | 5.070 | 5.300 | 5.070 | 5.230 | 5.230 | 2,288 |
| 2025-09-30 | 4.850 | 5.090 | 4.840 | 5.090 | 5.090 | 20,422 |
| 2025-09-29 | 4.900 | 5.010 | 4.850 | 4.950 | 4.950 | 8,160 |
| 2025-09-26 | 4.790 | 4.890 | 4.790 | 4.840 | 4.840 | 27,196 |
| 2025-09-25 | 4.860 | 4.890 | 4.770 | 4.790 | 4.790 | 13,230 |
| 2025-09-24 | 4.910 | 4.910 | 4.690 | 4.810 | 4.810 | 34,322 |
| 2025-09-23 | 5.090 | 5.100 | 4.770 | 4.770 | 4.770 | 1,921 |
| 2025-09-22 | 4.950 | 5.210 | 4.950 | 5.010 | 5.010 | 78,574 |
| 2025-09-19 | 4.780 | 4.920 | 4.690 | 4.690 | 4.690 | 8,458 |
| 2025-09-18 | 4.630 | 4.780 | 4.560 | 4.780 | 4.780 | 3,135 |
| 2025-09-17 | 4.870 | 4.870 | 4.580 | 4.580 | 4.580 | 15,296 |
| 2025-09-16 | 4.760 | 4.900 | 4.760 | 4.820 | 4.820 | 11 |
| 2025-09-15 | 4.650 | 4.680 | 4.570 | 4.600 | 4.600 | 1,650 |
| 2025-09-12 | 4.800 | 4.800 | 4.650 | 4.650 | 4.650 | 1,625 |
| 2025-09-11 | 4.660 | 4.820 | 4.580 | 4.820 | 4.820 | 4,614 |
| 2025-09-10 | 4.860 | 4.860 | 4.680 | 4.680 | 4.680 | 18,488 |
| 2025-09-09 | 4.800 | 4.810 | 4.800 | 4.810 | 4.810 | 855 |
| 2025-09-08 | 5.000 | 5.090 | 4.770 | 4.770 | 4.770 | 50,112 |
| 2025-09-05 | 5.090 | 5.140 | 4.950 | 5.060 | 5.060 | 40,388 |
| 2025-09-04 | 5.220 | 5.220 | 4.970 | 5.020 | 5.020 | 25,935 |
| 2025-09-03 | 5.000 | 5.350 | 4.940 | 5.170 | 5.170 | 34,420 |
| 2025-09-02 | 4.940 | 5.120 | 4.940 | 4.980 | 4.980 | 2,388 |
| 2025-09-01 | 4.910 | 4.910 | 4.910 | 4.910 | 4.910 | 172 |
| 2025-08-29 | 5.070 | 5.070 | 4.910 | 4.910 | 4.910 | 2,974 |
| 2025-08-28 | 5.100 | 5.100 | 4.940 | 4.980 | 4.980 | 6,068 |
| 2025-08-27 | 4.920 | 5.490 | 4.860 | 5.490 | 5.490 | 412 |
| 2025-08-26 | 4.990 | 4.990 | 4.850 | 4.920 | 4.920 | 439 |
| 2025-08-25 | 5.330 | 5.500 | 4.930 | 4.940 | 4.940 | 41,133 |
| 2025-08-22 | 5.500 | 5.500 | 5.280 | 5.430 | 5.430 | 3,107 |
| 2025-08-21 | 5.260 | 5.470 | 5.220 | 5.470 | 5.470 | 485 |
| 2025-08-20 | 5.980 | 5.980 | 5.440 | 5.540 | 5.540 | 933 |
| 2025-08-19 | 5.840 | 5.840 | 5.600 | 5.690 | 5.690 | 25,209 |
| 2025-08-18 | 5.930 | 5.960 | 5.760 | 5.780 | 5.780 | 13,548 |
| 2025-08-15 | 5.570 | 5.950 | 5.410 | 5.950 | 5.950 | 17,694 |
| 2025-08-14 | 5.530 | 5.530 | 5.370 | 5.510 | 5.510 | 173 |
| 2025-08-13 | 5.080 | 5.500 | 5.080 | 5.500 | 5.500 | 11,698 |
| 2025-08-12 | 4.900 | 5.030 | 4.800 | 5.030 | 5.030 | 6,471 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (BRL). Adjusted close accounts for splits and dividends. Educational only, not financial advice.